108 related articles for article (PubMed ID: 28583852)
1. B-cell activating factor deficiency suppresses splenomegaly during Leishmania donovani infection.
Omachi S; Fujii W; Azuma N; Morimoto A; Sanjoba C; Matsumoto Y; Goto Y
Biochem Biophys Res Commun; 2017 Aug; 489(4):528-533. PubMed ID: 28583852
[TBL] [Abstract][Full Text] [Related]
2. Variable dependency on BAFF in IgG antibody production during Leishmania infection.
Azuma N; Omachi S; Hanazawa W; Morimoto A; Sanjoba C; Matsumoto Y; Fujii W; Goto Y
Parasitol Int; 2020 Feb; 74():101997. PubMed ID: 31626986
[TBL] [Abstract][Full Text] [Related]
3. Pathological roles of MRP14 in anemia and splenomegaly during experimental visceral leishmaniasis.
Ishizuka K; Fujii W; Azuma N; Mizobuchi H; Morimoto A; Sanjoba C; Matsumoto Y; Goto Y
PLoS Negl Trop Dis; 2020 Jan; 14(1):e0008020. PubMed ID: 31961866
[TBL] [Abstract][Full Text] [Related]
4. IRF-5 Expression in Myeloid Cells Is Required for Splenomegaly in
Mai LT; Smans M; Silva-Barrios S; Fabié A; Stäger S
Front Immunol; 2019; 10():3071. PubMed ID: 32038622
[TBL] [Abstract][Full Text] [Related]
5. Comparison Between Immuno-Clinicopathological Features of Experimental and Human Visceral Leishmaniasis by Leishmania donovani.
Saini S; Dube A; Sahasrabuddhe AA; Thakur CP; Joshi S; Rawat K; Rai AK
Acta Parasitol; 2020 Mar; 65(1):57-67. PubMed ID: 31578670
[TBL] [Abstract][Full Text] [Related]
6. Infection pattern and immune response in the spleen and liver of BALB/c mice intracardially infected with Leishmania donovani amastigotes.
Mukherjee P; Ghosh AK; Ghose AC
Immunol Lett; 2003 Apr; 86(2):131-8. PubMed ID: 12644314
[TBL] [Abstract][Full Text] [Related]
7. The fate of heterologous CD4+ T cells during Leishmania donovani infection.
Polley R; Zubairi S; Kaye PM
Eur J Immunol; 2005 Feb; 35(2):498-504. PubMed ID: 15682458
[TBL] [Abstract][Full Text] [Related]
8. B cell-deficient mice are highly resistant to Leishmania donovani infection, but develop neutrophil-mediated tissue pathology.
Smelt SC; Cotterell SE; Engwerda CR; Kaye PM
J Immunol; 2000 Apr; 164(7):3681-8. PubMed ID: 10725726
[TBL] [Abstract][Full Text] [Related]
9. Chronic Leishmania donovani infection promotes bystander CD8+-T-cell expansion and heterologous immunity.
Polley R; Sanos SL; Prickett S; Haque A; Kaye PM
Infect Immun; 2005 Dec; 73(12):7996-8001. PubMed ID: 16299292
[TBL] [Abstract][Full Text] [Related]
10. The capacity to produce IFN-gamma rather than the presence of interleukin-4 determines the resistance and the degree of susceptibility to Leishmania donovani infection in mice.
Lehmann J; Enssle KH; Lehmann I; Emmendörfer A; Lohmann-Matthes ML
J Interferon Cytokine Res; 2000 Jan; 20(1):63-77. PubMed ID: 10670653
[TBL] [Abstract][Full Text] [Related]
11. Leishmania donovani: dynamics of L. donovani evasion of innate immune cell attack due to malnutrition in visceral leishmaniasis.
Kumar V; Bimal S; Singh SK; Chaudhary R; Das S; Lal C; Pandey K; Das VR; Das P
Nutrition; 2014 Apr; 30(4):449-58. PubMed ID: 24607302
[TBL] [Abstract][Full Text] [Related]
12. 115 kDa serine protease confers sustained protection to visceral leishmaniasis caused by Leishmania donovani via IFN-γ induced down-regulation of TNF-α mediated MMP-9 activity.
Choudhury R; Das P; De T; Chakraborti T
Immunobiology; 2013 Jan; 218(1):114-26. PubMed ID: 22440312
[TBL] [Abstract][Full Text] [Related]
13. Cross-protective efficacy of a prophylactic Leishmania donovani DNA vaccine against visceral and cutaneous murine leishmaniasis.
Aguilar-Be I; da Silva Zardo R; Paraguai de Souza E; Borja-Cabrera GP; Rosado-Vallado M; Mut-Martin M; García-Miss Mdel R; Palatnik de Sousa CB; Dumonteil E
Infect Immun; 2005 Feb; 73(2):812-9. PubMed ID: 15664920
[TBL] [Abstract][Full Text] [Related]
14. Tinospora cordifolia as a protective and immunomodulatory agent in combination with cisplatin against murine visceral leishmaniasis.
Sachdeva H; Sehgal R; Kaur S
Exp Parasitol; 2014 Feb; 137():53-65. PubMed ID: 24370645
[TBL] [Abstract][Full Text] [Related]
15. Hemophagocytosis in Experimental Visceral Leishmaniasis by Leishmania donovani.
Morimoto A; Omachi S; Osada Y; Chambers JK; Uchida K; Sanjoba C; Matsumoto Y; Goto Y
PLoS Negl Trop Dis; 2016 Mar; 10(3):e0004505. PubMed ID: 26942577
[TBL] [Abstract][Full Text] [Related]
16. Studies on the protective efficacy of freeze thawed promastigote antigen of Leishmania donovani along with various adjuvants against visceral leishmaniasis infection in mice.
Thakur A; Kaur H; Kaur S
Immunobiology; 2015 Sep; 220(9):1031-8. PubMed ID: 26001730
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-27R (WSX-1/T-cell cytokine receptor) gene-deficient mice display enhanced resistance to leishmania donovani infection but develop severe liver immunopathology.
Rosas LE; Satoskar AA; Roth KM; Keiser TL; Barbi J; Hunter C; de Sauvage FJ; Satoskar AR
Am J Pathol; 2006 Jan; 168(1):158-69. PubMed ID: 16400019
[TBL] [Abstract][Full Text] [Related]
18. Pure protein from Leishmania donovani protects mice against both cutaneous and visceral leishmaniasis.
Rachamim N; Jaffe CL
J Immunol; 1993 Mar; 150(6):2322-31. PubMed ID: 8450215
[TBL] [Abstract][Full Text] [Related]
19. Investigation into the presence of Leishmania antibodies in patients with hepatosplenomegaly.
Kabil SM; Morsy TA; Yousef SM
J Egypt Soc Parasitol; 1988 Jun; 18(1):29-34. PubMed ID: 3373056
[No Abstract] [Full Text] [Related]
20. Genetically Modified Live Attenuated Leishmania donovani Parasites Induce Innate Immunity through Classical Activation of Macrophages That Direct the Th1 Response in Mice.
Bhattacharya P; Dey R; Dagur PK; Kruhlak M; Ismail N; Debrabant A; Joshi AB; Akue A; Kukuruga M; Takeda K; Selvapandiyan A; McCoy JP; Nakhasi HL
Infect Immun; 2015 Oct; 83(10):3800-15. PubMed ID: 26169275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
